Intra-abdominal Pressure Monitoring in Patients With Open Abdomen Undergoing Early Closure

Sponsor
Michigan State University (Other)
Overall Status
Completed
CT.gov ID
NCT02107781
Collaborator
ConvaTec Inc. (Industry)
17
1
46
0.4

Study Details

Study Description

Brief Summary

The investigators will monitor the pressure generated inside the abdomen in a patient in whom the surgeon, for whatever reason, felt that the abdomen could not be closed at the initial operation. The investigators will aggressively treat rises in intra-abdominal pressure and see what changes, if any are found when the abdomen finally is closed.

Condition or Disease Intervention/Treatment Phase
  • Device: AbViser abdominal compartment pressure measuring device

Detailed Description

The detrimental effects of elevated intra-abdominal compartment pressure have been known for some time and are actively managed by most surgical critical care physicians. Similarly, it is well known that occasionally the abdomen cannot be immediately closed in some patients due to concern of elevated intra-abdominal pressure or ongoing contamination; these patients typically stay in hospital, often in expensive ICU's until final closure - and even then, some patients do not get definitive reconstruction of the abdominal wall until many months later, again adding to the expense of their care. Thus, there has been a move to give these patients early, aggressive closure of the abdomen, often using a combination of negative pressure wound therapy and biologic mesh. Currently these groups of patients who have early aggressive closure are incompletely studied; although abdominal compartment pressure measurements are routinely made on them, this is not commonly done intra-operatively when closure is being performed; nor have these patients been studied with continuous monitoring. This is especially striking considering the occlusive nature of negative wound therapy dressings: anecdotal increases in abdominal pressures have been noted in these patients, sometimes to dangerous levels. As there is accumulating evidence that diligent management of intra-abdominal pressure can improve outcomes in a variety of patients, there is an opportunity to apply accurate monitoring to a patient group that is also likely to benefit.

The investigators propose a prospective observational study on patients who are unable to be definitively closed at the time of surgery and are candidates for early aggressive abdominal closure. The investigators will monitor abdominal pressure using the AbViser continuous abdominal pressure monitoring device to ascertain whether there are episodes if intra-abdominal hypertension in these patients, and whether this improves or not after definitive closure. The research team will then attempt to correlate abdominal pressure measurements to outcomes. Finally the team will compare patients to historical controls using propensity scoring to explore differences in outcome.

Intra-abdominal pressure monitoring will be initiated when a patient has been identified as requiring an open abdomen. The monitoring will be done until the patient's abdominal wound has been closed and there are no elevated measurements. Once the patient has been discharged from the intensive care unit, the AbViser system will be discontinued. Patients will continue to be followed for the duration of their hospital stay and outcome measures will be assessed until discharge from the hospital, an expected average of 2 - 3 weeks.

Study Design

Study Type:
Observational
Actual Enrollment :
17 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Observational Study of Continuous Intra-abdominal Pressure Monitoring in Patients With Postoperative Open Abdomen Undergoing Early Intervention and Closure
Study Start Date :
Mar 1, 2012
Actual Primary Completion Date :
Jan 1, 2016
Actual Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Patients with open abdomen

Patients in a critical care unit with abdomen that was not closed during initial operation & will have intra-abdominal pressure monitoring using the AbViser abdominal compartment pressure measuring device.

Device: AbViser abdominal compartment pressure measuring device
AbViser AutoValve IAP Monitoring Device will be used on all patient enrolled in the research study.
Other Names:
  • AbViser system
  • IAP system
  • Abdominal compartment syndrome monitor
  • Outcome Measures

    Primary Outcome Measures

    1. Intra-abdominal pressure (IAP) Measurements [From the time when the patient has surgery & the abdomen is left open, immediately after abdomen is closed & until the patient's IAP system is discontinued, an expected average of 1 - 3 weeks.]

      The IAP will be recorded using the AbVisor system when abdomen is open, after surgical closure and will continue until the IAP system is discontinued

    Secondary Outcome Measures

    1. Length of time in critical care unit [From the time the patient is admitted to the critical care unit until discharged to a step-down unit. Measured immediately after discharge from critical care unit, an expected average of 1 - 3 weeks.]

      The length of time subjects require monitoring in a critical care unit.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Postoperative Surgical Patients who have not undergone abdominal closure, irrespective of the type of dressing used to protect the viscera
    Exclusion Criteria:
    • Age less than 18 years

    • Coagulopathy

    • Moribund/not expected to survive 48 hrs

    • Patients in whom there is not a commitment to life supporting therapy

    • Patients who have had definitive closure at the time of operation

    • Patients in whom abdominal closure is not planned or not feasible

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sparrow Health System Lansing Michigan United States 48912

    Sponsors and Collaborators

    • Michigan State University
    • ConvaTec Inc.

    Investigators

    • Principal Investigator: Benjamin D. Mosher, MD, Michigan State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Benjamin Mosher, Assistant Professor, Department of Surgery, Michigan State University
    ClinicalTrials.gov Identifier:
    NCT02107781
    Other Study ID Numbers:
    • r041998
    First Posted:
    Apr 8, 2014
    Last Update Posted:
    Jun 11, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Benjamin Mosher, Assistant Professor, Department of Surgery, Michigan State University

    Study Results

    No Results Posted as of Jun 11, 2020